Recruiting studies: Hypogammaglobulinemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202052 Analysis of the Role of IgE Proteoforms in Health and Disease
Phase N/A · 1 location(s) · KU Leuven · NCT07328178 A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Pre
Phase 3 · 62 location(s) · Grifols Therapeutics LLC · NCT05645107 Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy
Phase N/A · 1 location(s) · University of Alberta · NCT06989541 IVIG vs SCIG in CIDP
Phase 1 · 1 location(s) · Rutgers, The State University of New Jersey · NCT05584631 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621 V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · 1 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441 Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001244 Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06976476 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00967785 Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
Phase 3 · 1 location(s) · Octapharma · NCT07220915 Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05357781

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.